Jeffrey Hubbell
Co-founder, Office of the Chief Scientific Officer
Pharmaceuticals
ANOKION
Switzerland
Biography
Jeff is a professor and founder of the Institute of Bioengineering at the Ecole Polytechnique Fédérale de Lausanne (Swiss Federal Institute of Technology, EPFL), and a professor at the Institute of Molecular Engineering at the University of Chicago. His research focuses on engineering approaches to immunomodulation, drug delivery, and regenerative medicine. Jeff has successfully spun-out several companies based on technology from his laboratories, co-founding Focal, Inc. (Lexington, MA) and founding Kuros Biosurgery AG (Zurich, Switzerland). He is a fellow of the American Institute of Medical and Biological Engineering and a Member of the National Academy of Engineering.
Research Interest
Business
